Natureza Blog: Antibiotic Research and Development Articles
Opinion: We Need More than New Antibiotics to Fight Resistance
Opinion: We Need More than New Antibiotics to Fight Resistance Neil S. Greenspan and Arturo Casadevall | Nov 1, 2019 Metabolic disrupters, phages, and other approaches are going to be needed to treat the broadest possible range of patients infected by bacterial pathogens resistant to multiple drugs. In [...]
Antibiotic Resistance: A Rundown of a Global Crisis
Antibiotic resistance: a rundown of a global crisis National Center for Biotechnology Information, U.S. National Library of Medicine The advent of multidrug resistance among pathogenic bacteria is imperiling the worth of antibiotics, which have previously transformed medical sciences. The crisis of antimicrobial resistance has been ascribed to the [...]
The Rise of Superbugs: Facing the Antibiotic Resistance Crisis
The rise of superbugs: Facing the antibiotic resistance crisis By Maria Cohut, Ph.D. | November 18, 2019 | Medical News Today While medical research has helped us overcome many health threats, we now face a new type of crisis: Many dangerous bacteria are becoming resistant to the drugs [...]
The World Is Running Out Of Antibiotics, WHO Report Confirms
The World Is Running Out Of Antibiotics, WHO Report Confirms 20 September 2017 | WHO News Release | Geneva A report, Antibacterial agents in clinical development – an analysis of the antibacterial clinical development pipeline, including tuberculosis, launched today by WHO shows a serious lack of new antibiotics [...]
Review on Antimicrobial Resistance
Review on Antimicrobial Resistance (AMR) Wellcome Trust & UK Department of Health The Review on Antimicrobial Resistance (AMR), was commissioned in July 2014 by the UK Prime Minister, who asked economist Jim O’Neill to analyse the global problem of rising drug resistance and propose concrete actions to tackle [...]
Innovative Ways to Pay for New Antibiotics Will Help Fight Superbugs
Innovative Ways to Pay for New Antibiotics Will Help Fight Superbugs 11 April 2018 | STAT | Kevin Outterson, Executive Director CARB-X Antibiotics are the most important drug class in human history. Without them, minor infections like strep throat or urinary tract infections could turn deadly. Heart surgery, [...]
Antimicrobial Resistance
Antimicrobial Resistance 20 August 2017 | WHO News Release | Geneva Many of the medical breakthroughs of the last century could be lost through the spread of antimicrobial resistance. Previously curable infectious diseases may become untreatable and spread throughout the world. This has already started to happen. The [...]
Antibiotics in Meat Could Be Damaging Our Guts
Antibiotics in Meat Could Be Damaging Our Guts 25 May 2018 | NY Times | By William D. Cohan The F.D.A. banned the use of antibiotics for growth promotion in animals last year. One organic cattle farmer is sure the ban is being flouted. In 2015, Sandy Lewis, a [...]
Superbugs: An Arms Race against Bacteria
Superbugs: An Arms Race against Bacteria by William Hall (Author), Anthony McDonnell (Author), Jim O’Neill Chair of a formal Review on Antimicrobial Resistance (AMR) (Author) Antibiotics are powerful drugs that can prevent and treat infections, but they are becoming less effective as a result of drug resistance. Resistance [...]
High Levels Of Antibiotic Resistance Found Worldwide
High Levels Of Antibiotic Resistance Found Worldwide, New Data Shows 29 January 2018 | WHO News Release | Bangkok WHO’s first release of surveillance data on antibiotic resistance reveals high levels of resistance to a number of serious bacterial infections in both high- and low-income countries. WHO’s new [...]
The Truly Staggering Cost of Inventing New Drugs
The Truly Staggering Cost Of Inventing New Drugs 10 February 2012 | FORBES | Matthew Herper Matthew Herper covers science and medicine for FORBES. During the Super Bowl, a representative of the pharmaceutical company Eli Lilly posted the on the company’s corporate blog that the average [...]
Critical Assessment of Incentive Strategies for Development of Novel Antibiotics
A Critical Assessment of Incentive Strategies for Development of Novel Antibiotics 31 October 2014 LSE Health, London School of Economics and Political Science Matthew Renwick, David Brogan, & Elias Mossialos1 In recent years, a concern has emerged in the public health arena regarding the deadly combination of increasing [...]